Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-KEAP1 Polyclonal Antibody (HC302024)

Price(USD):
Spec:
  • 50ug
  • 100ug
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HC302024
Species reactivityHuman, Mouse, Rat
ApplicationsELISA, IHC, WB
Host speciesRabbit
IsotypeIgG
Clonality Polyclonal
Immunogen E. coli - derived recombinant Human KEAP1 (Gly325-Cys624).
Target INrf2, INRF2, KLHL19, KEAP1, KIAA0132, Kelch-like ECH-associated protein 1, Cytosolic inhibitor of Nrf2, Kelch-like protein 19
Purification Purified by antigen affinity column.
Accession Q14145
Form Liquid
Storage buffer 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:5000-1:20000
IHC 1:50-1:500
WB 1:500-1:2000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background

Kelch-like ECH-associated protein 1 (KEAP1) is a ~69 kDa protein. Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that regulates the response to oxidative stress by targeting NFE2L2/NRF2 for ubiquitination. KEAP1 acts as a key sensor of oxidative and electrophilic stress: in normal conditions, the BCR(KEAP1) complex mediates ubiquitination and degradation of NFE2L2/NRF2, a transcription factor regulating expression of many cytoprotective genes. In response to oxidative stress, different electrophile metabolites trigger non-enzymatic covalent modifications of highly reactive cysteine residues in KEAP1, leading to inactivate the ubiquitin ligase activity of the BCR(KEAP1) complex, promoting NFE2L2/NRF2 nuclear accumulation and expression of phase II detoxifying enzymes. In response to selective autophagy, KEAP1 is sequestered in inclusion bodies following its interaction with SQSTM1/p62, leading to inactivation of the BCR(KEAP1) complex and activation of NFE2L2/NRF2. The BCR(KEAP1) complex also mediates ubiquitination of SQSTM1/p62, increasing SQSTM1/p62 sequestering activity and degradation.

1. Zhang, DD. et al. (2003) Molecular and cellular biology 23, 8137-51. PMID: 14585973
2. Strachan, GD. et al. (2004) Biochemistry 43, 12113-22. PMID: 15379550
3. Zhang, DD. et al. (2004) Molecular and cellular biology 24, 10941-53. PMID: 15572695
4. Furukawa, M. et al. (2005) Molecular and cellular biology 25, 162-71. PMID: 15601839
5. Zhang, DD. et al. (2005) The Journal of biological chemistry 280, 30091-9. PMID: 15983046
6. Cai, C. et al. (2023) Nature communications 14, 3648. PMID: 37339955
7. Eggler, AL. et al. (2005) Proceedings of the National Academy of Sciences of the United States of America 102, 10070-5. PMID: 16006525
8. Gao, L. et al. (2007) The Journal of biological chemistry 282, 2529-37. PMID: 17127771
10. Eggler, AL. et al. (2009) The Biochemical journal 422, 171-80. PMID: 19489739
Note For research use only.
Images
References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list